FATE THERAPEUTICS INC
FATE·31189P102·US·Common Stock·Healthcare - Biotechnology-Activist
FATE (FATE THERAPEUTICS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($12.1M), VANGUARD CAPITAL MANAGEMENT LLC ($5M), VANGUARD PORTFOLIO MANAGEMENT LLC ($5M). Net institutional sentiment: Mixed.
88
Holders
Avg rating(25 Elite)
$56.8M
Total Value
60% (93)
Fund Consensus
47 buying - 31 selling
Who's Trading
InsiderTCTAHL CINDYExercise 44K shMay 6, 2026
InsiderTCTAHL CINDYExercise 122K shMay 6, 2026
InsiderESEPSTEIN ROBERT SExercise 25K shMay 5, 2026
InsiderRHRASTETTER WILLIAM HExercise 25K shMay 5, 2026
ActivistRERedmile Group, LLC14.9%Apr 22, 2026
InsiderTCTAHL CINDYSell $11KJan 9, 2026
InsiderVBValamehr BahramSell $6KJan 9, 2026
13F: Insider & Congress:
Showing 1-20 of 93
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer